Reproductive outcomes following hydroxychloroquine use for autoimmune diseases: a systematic review and meta-analysis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Reproductive outcomes following hydroxychloroquine use for autoimmune diseases: a systematic review and meta-analysis
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Volume 81, Issue 5, Pages 835-848
Publisher
Wiley
Online
2015-12-24
DOI
10.1111/bcp.12872
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- O58. Longterm Outcomes of Children Born to Mothers with SLE Exposed to Hydroxychloroquine in Pregnancy
- (2017) Mary Gayed et al. RHEUMATOLOGY
- Hydroxychloroquine as an anti-thrombotic in antiphospholipid syndrome
- (2015) Cristina Belizna AUTOIMMUNITY REVIEWS
- Pregnancy-related issues in women with systemic lupus erythematosus
- (2014) Abha G. Singh et al. International Journal of Rheumatic Diseases
- Hydroxychloroquine restores trophoblast fusion affected by antiphospholipid antibodies
- (2014) T. Marchetti et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Hydroxychloroquine: A multifaceted treatment in lupus
- (2014) Nathalie Costedoat-Chalumeau et al. PRESSE MEDICALE
- Effect of Hydroxychloroquine on Antiphospholipid Antibody-Induced Changes in First Trimester Trophoblast Function
- (2013) Caroline R. Albert et al. AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
- Pathogenesis of pregnancy complications in systemic lupus erythematosus
- (2013) Monika Ostensen et al. CURRENT OPINION IN RHEUMATOLOGY
- Pregnancy outcome following in utero exposure to hydroxychloroquine: A prospective comparative observational study
- (2013) Orna Diav-Citrin et al. REPRODUCTIVE TOXICOLOGY
- Brief Report: Risk of Adverse Fetal Outcomes Associated With Immunosuppressive Medications for Chronic Immune-Mediated Diseases in Pregnancy
- (2013) William O. Cooper et al. Arthritis & Rheumatology
- Prevalence and significance of previously undiagnosed rheumatic diseases in pregnancy
- (2012) Arsenio Spinillo et al. ANNALS OF THE RHEUMATIC DISEASES
- Maternal Use of Hydroxychloroquine Is Associated With a Reduced Risk of Recurrent Anti-SSA/Ro-Antibody–Associated Cardiac Manifestations of Neonatal Lupus
- (2012) Peter M. Izmirly et al. CIRCULATION
- Hydroxychloroquine reduces binding of antiphospholipid antibodies to syncytiotrophoblasts and restores annexin A5 expression
- (2011) Xiao-Xuan Wu et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Hydroxychloroquine: From Malaria to Autoimmunity
- (2011) Ilan Ben-Zvi et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Hydroxychloroquine in systemic lupus erythematosus and rheumatoid arthritis and its safety in pregnancy
- (2011) Crispin Abarientos et al. Expert Opinion On Drug Safety
- Visual neurophysiological dysfunction in infants exposed to hydroxychloroquine in utero
- (2010) Isabelle Ingster-Moati et al. ACTA PAEDIATRICA
- Evaluation of the risk of anti-SSA/Ro-SSB/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine
- (2010) P. M. Izmirly et al. ANNALS OF THE RHEUMATIC DISEASES
- Hydroxychloroquine in SLE: old drug, new perspectives
- (2010) Thomas Dörner Nature Reviews Rheumatology
- Visual neurophysiological dysfunction in infants exposed to hydroxychloroquine in utero
- (2009) F Renault et al. ACTA PAEDIATRICA
- Systematic review of hydroxychloroquine use in pregnant patients with autoimmune diseases
- (2009) Kirk Sperber et al. Pediatric Rheumatology
- Hydroxychloroquine: the cornerstone of lupus therapy
- (2008) G Ruiz-Irastorza et al. LUPUS
- Previous antimalarial therapy in patients diagnosed with lupus nephritis: Influence on outcomes and survival
- (2008) A Sisó et al. LUPUS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started